Loading...

TCRT ALAUNOS THERAPEUTICS INC Management Changes 8-K Filing

LNS

TCRT

ALAUNOS THERAPEUTICS INC

(TCRT)

2025 8-K

Compliance Regained

Increase in authorized shares

Departures and Appointments

Equity Offerings

Equity Offerings

Equity Offerings

Director Resignation

Board Compensation

License Termination

Reverse Stock Split

Reverse Stock Split

Reverse Stock Split

Reverse Stock Split

Dismissal of Independent Re...

Annual Meeting Approval

Management Changes

Compliance regained with Na...

Reverse Stock Split

Reverse Stock Split

Appointment of Interim CEO

Appointment of Director and...

Management Changes

Resignation of Director

Management Departure

Financial Condition and Del...

Resignation and Appointment

Financial Results and Strat...

Voluntary Delisting

Annual Meeting Approval

Financial Results Announcement

License Agreement Amendment

Loan Agreement Amendment

Management Changes

Earnings Reports

Presentation and Press Release

External Links:

On July 1, 2025, Dale Curtis Hogue, Jr. resigned as CEO and Board member of Alaunos Therapeutics, Inc. and was replaced by Holger Weis on July 2, 2025, who will earn $275,000 annually and received an option for 130,000 shares at $5.06 each.

AI Assistant

ALAUNOS THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.